Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Doc Stone's Bierstube und Trading Room -- Ignore unavailable to you. Want to Upgrade?

To: W.F. Schwertley who wrote (583)	9/8/1999 10:01:00 AM
From: M. Frank Greiffenstein	Respond to of 638

Repeat of 1998... The 1999 market has pretty much kept in sync with last years market. In fact, they hit new market highs on the same day in July! I see an erosion in late September and a big sell off in October. Things will be pretty tepid in early January as the market awaits evdience on the qaulity of y2k fixes. Then off to the races again! DocStone

To: W.F. Schwertley who wrote (583)	10/17/1999 11:48:00 AM
From: M. Frank Greiffenstein	Respond to of 638

Adding HRC and HUM... I am changing the name of my "Franchise Dogs!" portfolio to the "Blood in the Streets!" portfolio. I like the analogy. siliconinvestor.com I am adding to new picks: Healthsouth and Humana. Humana(Nyse: HUM) $7.25 This provider of managed healthcare products and services trades at 0.1 times sales, 5.3 times EBITDA, 2.5 times book value and in the lower-end of its 12-month trading range. Insiders have been buying boatloads of this stock. Executives have purchased over 1 million shares in the open market at prices ranging from $8.10 to $9.69. You can now get it for 6 and shrapnel. Consensus estimates have the company earning $0.65 per share in 1999 and $0.75 per share in 2000. Humana trades at just 9.7 times 2000 estimates. This is a sizeable discount to the anticipated 15.4% earnings growth. Think of it in demographic terms: What famous generation is now approaching the age of multiple diseases? Healthsouth(Nyse: HRC) $5.63 Another provider of clinical and surgical healthcare services trades at 0.6 times sales, 3 times EBITDA Management has publicly stated that it thinks that the stock is undervalued. The company has repurchased over 15 million shares , and insiders have been buying the stock for some time now. In a filing this past week, executives purchased 6.1 million shares in the open market at an average price of $5.74 since September. Remember, insiders are usually too early, but this stock is so cheap. Wall Street expects that the company will earn $0.85 per share in 1999 and $0.71 per share in 2000. Although earnings are expected to decrease, at 8 times fiscal 2000 earnings it's hard not to see the value in this company. The risks? Plenty. HUM is the target of a major lawsuit by plaintiff attorneys enriched by the tobacco settlement. But remember this: There are still a lot of problems at the bottom. All this crap is discounted into the stock price. DocStone